Valuation: Photocure ASA

Market Cap 1.35B 145M 130M 121M 109M 204M 13.84B 206M 1.44B 574M 7.24B 545M 534M 22.99B P/E 2026 *
17.9x
P/E 2027 * 72.8x
Enterprise Value 1.18B 127M 114M 105M 95.55M 179M 12.11B 181M 1.26B 502M 6.34B 477M 467M 20.12B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.8x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day-5.00%
1 week-5.94%
Current month-5.57%
1 month-3.06%
3 months-16.37%
6 months-29.42%
Current year-33.47%
1 week 47.2
Extreme 47.2
50.7
1 month 47.2
Extreme 47.2
51
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 46.25
Extreme 46.25
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 A BuyCompany 11,355 0.0419%
4/2/25 A BuyCompany 8,997 0.0332%
3/31/25 A BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.94%-11.38%-18.66% 144M
+0.58%+1.53%+57.32%+128.06% 1,143B
+0.87%+5.12%+44.97%+84.31% 647B
+0.52%+0.94%+26.35%+102.61% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-1.02%-6.36%+61.27%+36.69% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.62%+2.79%+54.25%+71.19% 242B
+0.39%+4.00%+35.49%+105.37% 197B
Average -0.33%+0.74%+35.46%+65.25% 402.77B
Weighted average by Cap. +0.32%+0.71%+44.58%+87.10%

Financials

2026 *2027 *
Net sales 657M 70.89M 63.6M 58.8M 53.25M 99.49M 6.75B 101M 703M 280M 3.53B 266M 260M 11.22B 664M 71.71M 64.34M 59.49M 53.88M 101M 6.83B 102M 711M 283M 3.57B 269M 263M 11.35B
Net income 75.33M 8.13M 7.3M 6.75M 6.11M 11.41M 775M 11.55M 80.65M 32.12M 405M 30.52M 29.87M 1.29B 18.33M 1.98M 1.78M 1.64M 1.49M 2.78M 188M 2.81M 19.63M 7.82M 98.63M 7.43M 7.27M 313M
Net Debt -168M -18.1M -16.24M -15.01M -13.6M -25.4M -1.72B -25.71M -180M -71.5M -902M -67.92M -66.49M -2.86B -152M -16.37M -14.69M -13.58M -12.3M -22.98M -1.56B -23.26M -162M -64.68M -816M -61.44M -60.14M -2.59B
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
28/10/26 NOK 47.50 -5.00% 269,590
27/10/26 NOK 50.00 +0.81% 142,661
26/10/26 NOK 49.60 +1.22% 24,245
23/10/26 NOK 49.00 -0.61% 33,135
22/10/26 NOK 49.30 -2.38% 22,917
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
50.00NOK
Average target price
78.00NOK
Spread / Average Target
+56.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Photocure ASA